Global Endometrial Ablation Devices Market – Industry Trends and Forecast to 2030

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Endometrial Ablation Devices Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Endometrial Ablation Devices Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Endometrial Ablation Devices Market size in 2022 - 3.46 and 2030 - 5.56, highlighting the projected market growth. USD 3.46 Billion USD 5.56 Billion 2022 2030
Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 3.46 Billion
Diagram Market Size (Forecast Year)
USD 5.56 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • AEGEA MedicalInc
  • Boston Scientific Corporation CooperSurgicalInc
  • HologicInc.
  • IDOMAN-MED
  • Minerva SurgicalInc

Global Endometrial Ablation Devices Market, By Device Type (Hysteroscopy devices, Thermal balloon ablators, Radiofrequency endometrial ablation devices, Hydrothermal ablators, Electrical ablators, Others), End-Use (Hospitals, Clinics, Ambulatory Surgical Centres, Others) – Industry Trends and Forecast to 2030.

Endometrial Ablation Devices Market

 Endometrial Ablation Devices Market Analysis and Size

According to the study titled "Radiofrequency endometrial ablation with a novel endometrial tip for the management of heavy menstrual bleeding and abnormal uterine bleeding: a prospective study," published in July 2020, the safety and efficacy of a radiofrequency ablation system with a new endometrial tip (RFA-EMT) for heavy menstrual bleeding (HMB) or abnormal uterine bleeding (AUB) were 97.4% and 100%, respectively. Thus, the increased safety and efficacy of the radiofrequency ablation system is expected to drive segment growth during the forecast period.

Data Bridge Market Research analyses that the endometrial ablation devices market which is USD 3.46 billion in 2022, is expected to reach USD 5.56 billion by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Endometrial Ablation Devices Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Device Type (Hysteroscopy devices, Thermal balloon ablators, Radiofrequency endometrial ablation devices, Hydrothermal ablators, Electrical ablators, Others), End-Use (Hospitals, Clinics, Ambulatory Surgical Centres, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

AEGEA Medical, Inc (U.S.), Boston Scientific Corporation (U.S.), CooperSurgical, Inc (U.S.), Hologic, Inc. (U.S.), IDOMAN-MED (Canada), Minerva Surgical, Inc (U.S.), Olympus Corporation (Japan), Omnitech Systems, Inc (U.S.) and Medtronic (Ireland)

Market Opportunities

  • Rising technological developments

Market Definition

Endometrial ablation is a medical procedure that allows for the removal of endometrium from the uterine wall. Endometrium ablation aids in the destruction of such thin layers to stop abnormal heavy uterine bleeding, and it is highly recommended when uterine bleeding is no longer controlled by medications.

Endometrial Ablation Devices Market Dynamics

Drivers

  • Rise in the prevalence of gynaecological disorders

The rise in the prevalence of gynaecological disorders such as cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD (polycystic ovarian disease) in women is a major factor driving market growth. Cervical cancer is the fourth most common cancer in women worldwide, according to World Health Organization Updates in February 2022, with 604 000 new cases and 342 000 deaths by 2020. Low- and middle-income countries will account for nearly 90% of new cases and deaths globally by 2020. As a result, the increasing prevalence of gynaecological diseases is expected to drive market growth during the forecast period.

  • Rising prevalence of endometrial cancer

The rising prevalence of endometrial cancer is expected to drive segment expansion. According to the American Cancer Society's 2022 update, more than 600,000 endometrial cancer survivors are in the United States. According to the same source, approximately 65,950 new cases of cancer of the uterine body (uterine body or corpus) are expected to be diagnosed in 2022. As a result of the increasing prevalence of endometrial cancer, demand for endometrial ablation devices is expected to rise.

Opportunities

  • Rising technological developments

The increasing developments made by the key players in the ablation segment are also contributing to the market's growth. For instance, on Tuesday at the 50th Global Congress of the American Association of Gynecologic Laparoscopists (AAGL), Hologic, Inc. unveiled the NovaSure V5 global endometrial ablation (GEA) device in November 2021. .

Restraints/Challenges

  • Risks associated with endometrial ablation

Risk associated with endometrial ablation is the most significant factor among others acting as restraints, and it will further challenge the growth of the endometrial ablation devices market during the forecast period.

This endometrial ablation devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endometrial ablation devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Endometrial Ablation Devices Market

The healthcare sector has faced significant challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or limited to reduce the risk of viral transmission, because most chronic therapies were deemed non-urgent during the COVID-19 pandemic. Endometriosis surgery is prohibited during the fourth, fifth, and sixth months of the COVID-19 pandemic, according to a study published in October 2021 titled "Endometriosis Surgery During the First Wave of the COVID-19 Pandemic: A Brazilian Single Institution Experience." Many endometriosis patients had postponed appointments, diagnostic tests, and elective therapeutic procedures. As a result, the decrease in endometrial surgeries during COVID-19 significantly impacted market growth. However, as endometrial surgeries resume and COVID-19 cases decline, the market is expected to return to pre-pandemic levels soon.

Recent Developments

  • In 2022, CooperSurgical agreed to invest USD 875 million in Cook Medical's reproductive health portfolio, which includes fertility, obstetrics, gynaecology, and in vitro fertilization medical equipment.
  • In 2022, Inovus Medical released HystAR, a new high-fidelity hysteroscopy simulator. The HystARTM is Inovus' third hysteroscopy simulator, joining the highly successful Bozzini Hysteroscopy line, which has been on the market for several years.

Global Endometrial Ablation Devices Market Scope

The endometrial ablation devices market is segmented on the basis of device type and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

  • Hysteroscopy devices
  • Thermal balloon ablators
  • Radiofrequency endometrial ablation devices
  • Hydrothermal ablators
  • Electrical ablators
  • Others

 End-Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

Endometrial Ablation Devices Market Regional Analysis/Insights

The endometrial ablation devices market is analyzed and market size insights and trends are provided by country, device type and end-use as referenced above.

The countries covered in the endometrial ablation devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the endometrial ablation devices market due to increased prevalence of varicose veins, increased demand for minimally invasive treatment procedures. 

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the increased healthcare expenditure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The endometrial ablation devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for endometrial ablation devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the endometrial ablation devices market. The data is available for historic period 2011-2021.

Competitive Landscape and Endometrial Ablation Devices Market Share Analysis

The endometrial ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endometrial ablation devices market.

Some of the major players operating in the endometrial ablation devices market are:

  • AEGEA Medical, Inc (U.S.)
  • Boston Scientific Corporation (U.S.)
  • CooperSurgical, Inc (U.S.)
  • Hologic, Inc. (U.S.)
  • IDOMAN-MED (Canada)
  • Minerva Surgical, Inc (U.S.)
  • Olympus Corporation (Japan)
  • Omnitech Systems, Inc (U.S.)
  • Medtronic (Ireland)

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1. INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2. MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL ENDOMETRIAL ABLATION DEVICES SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS 

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3. MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6. INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7. INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8. COST ANALYSIS BREAKDOWN

9. TECHNONLOGY ROADMAP

10. INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11. REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12. REIMBURSEMENT FRAMEWORK

13. OPPUTUNITY MAP ANALYSIS

14. VALUE CHAIN ANALYSIS

15. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE

15.1 OVERVIEW

15.2 SYSTEM/EQUIPMENT

15.2.1 BY TYPE

15.2.1.1. RADIOFREQUENCY ABLATION DEVICES

15.2.1.1.1. MONOPOLAR RADIOFREQUENCY ABLATION DEVICES

15.2.1.1.2. BIOPOLAR RADIOFREQUENCY ABLATION DEVICES

15.2.1.2. CRYOABLATION DEVICES

15.2.1.2.1. PROBE CRYOABLATION DEVICES

15.2.1.2.2. BALLOON CRYOABLATION DEVICES

15.2.1.3. THERMAL BALLOON ABLATION DEVICES

15.2.1.3.1. HYDROTHERMAL BALLOON ABLATION DEVICES

15.2.1.3.2. GAS-FILLED THERMAL BALLOON ABLATION DEVICES

15.2.1.4. HYDROTHERMAL ABLATION DEVICES

15.2.1.5. MICROWAVE ABLATION DEVICES

15.2.1.6. LASER ABLATION DEVICES

15.2.1.7. OTHERS 

15.2.2 BY MODALITY

15.2.2.1. STANDALONE

15.2.2.2. PORTABLE

15.2.2.3. BENCHTOP

15.3 CONSUMABLES

15.3.1 ELECTRODE

15.3.1.1. ABLATION SINGLE ELECTRODE KITS

15.3.1.2. ABLATION CLUSTER ELECTRODE KITS

15.3.1.3. ABLATION MULTIPLE ELECTRODE KITS

15.3.2 ABLATION SYSTEM GROUNDING PAD

15.3.3 ENDOMETRIAL ABLATION PROBES

15.3.3.1. STERILE

15.3.3.2. NON-STERILE

15.3.4 CANNULA

15.3.5 NEEDLES

15.3.6 CATHETERS

15.3.7 OTHERS

15.4 OTHERS

16. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY

16.1 OVERVIEW

16.2 STANDALONE 

16.3 PORTABLE

16.4 BENCHTOP

17. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE

17.1 OVERVIEW

17.2 IN OFFICE PROCEDURE SITE

17.3 FACILITY BASED PROCEDURE SITE

18. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY

18.1 OVERVIEW

18.2 RADIOFREQUENCY ABLATION

18.3 CRYOABLATION

18.4 THERMAL BALLOON ABLATION

18.5 HYDROTHERMAL ABLATION

18.6 MICROWAVE ABLATION

18.7 LASER ABLATION

18.8 OTHERS

19. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE

19.1 OVERVIEW

19.2 ESECTOSCOPIC

19.2.1 SYSTEM/EQUIPMENT

19.2.2 CONSUMABLES

19.2.3 OTHERS

19.3 NON-RESECTOSCOPIC

19.3.1 SYSTEM/EQUIPMENT

19.3.2 CONSUMABLES

19.3.3 OTHERS

20. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION

20.1 OVERVIEW

20.2 ABNORMAL UTERINE BLEEDING (AUB)

20.2.1 SYSTEM/EQUIPMENT

20.2.2 CONSUMABLES

20.2.3 OTHERS

20.3 MENORRHAGIA (HEAVY MENSTRUAL BLEEDING)

20.3.1 SYSTEM/EQUIPMENT

20.3.2 CONSUMABLES

20.3.3 OTHERS

20.4 DYSMENORRHEA (PAINFUL MENSTRUATION)

20.4.1 SYSTEM/EQUIPMENT

20.4.2 CONSUMABLES

20.4.3 OTHERS

20.5 POLYPS

20.5.1 SYSTEM/EQUIPMENT

20.5.2 CONSUMABLES

20.5.3 OTHERS

20.6 FIBROIDS

20.6.1 SYSTEM/EQUIPMENT

20.6.2 CONSUMABLES

20.6.3 OTHERS

20.7 ADENOMYOSIS

20.7.1 SYSTEM/EQUIPMENT

20.7.2 CONSUMABLES

20.7.3 OTHERS

20.8 OTHERS

21. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP

21.1 OVERVIEW

21.2 PRE-MENOPAUSAL

21.3 PERI-MENOPAUSAL

21.4 POST-MENOPAUSAL

22. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER

22.1 OVERVIEW

22.2 HOSPITALS

22.2.1 BY TYPE

22.2.1.1. PRIVATE

22.2.1.2. PUBLIC

22.3 CLINICAL LABORATORIES

22.4 DIAGNOSTIC IMAGING CENTERS

22.5 INDEPENDENT TREATMENT CENTRES

22.6 CATHERIZATION LABORATORIES

22.7 AMBULATORY SURGICAL CENTERS

22.8 OTHERS

23. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL

23.1 OVERVIEW

23.2 DIRECT TENDER

23.3 RETAIL SALES

23.4 OTHERS

24. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, SWOT AND DBMR ANALYSIS 

25. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, COMPANY LANDSCAPE

25.1 COMPANY SHARE ANALYSIS: GLOBAL

25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

25.3 COMPANY SHARE ANALYSIS: EUROPE

25.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC

25.5 MERGERS & ACQUISITIONS

25.6 NEW PRODUCT DEVELOPMENT & APPROVALS

25.7 EXPANSIONS

25.8 REGULATORY CHANGES

25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

26. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY REGION

GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

26.1 NORTH AMERICA

26.1.1 U.S.

26.1.2 CANADA

26.1.3 MEXICO

26.2 EUROPE

26.2.1 GERMANY

26.2.2 FRANCE

26.2.3 U.K.

26.2.4 ITALY

26.2.5 SPAIN

26.2.6 RUSSIA

26.2.7 TURKEY

26.2.8 BELGIUM

26.2.9 NETHERLANDS

26.2.10 SWITZERLAND

26.2.11 DENMARK

26.2.12 NORWAY

26.2.13 SWEDEN

26.2.14 FINLAND

26.2.15 POLAND

26.2.16 REST OF EUROPE

26.3 ASIA-PACIFIC

26.3.1 JAPAN

26.3.2 CHINA

26.3.3 SOUTH KOREA

26.3.4 INDIA

26.3.5 AUSTRALIA

26.3.6 SINGAPORE

26.3.7 THAILAND

26.3.8 MALAYSIA

26.3.9 INDONESIA

26.3.10 PHILIPPINES

26.3.11 VIETNAM

26.3.12 NEW ZEALAND

26.3.13 TAIWAN

26.3.14 REST OF ASIA-PACIFIC

26.4 SOUTH AMERICA

26.4.1 BRAZIL

26.4.2 ARGENTINA

26.4.3 REST OF SOUTH AMERICA 

26.5 MIDDLE EAST AND AFRICA 

26.5.1 SOUTH AFRICA

26.5.2 SAUDI ARABIA

26.5.3 UAE

26.5.4 EGYPT

26.5.5 ISRAEL

26.5.6 OMAN

26.5.7 QATAR

26.5.8 BAHRAIN

26.5.9 REST OF MIDDLE EAST AND AFRICA

26.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 

27. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, COMPANY PROFILE

27.1 HOLOGIC, INC. 

27.1.1 COMPANY OVERVIEW

27.1.2 REVENUE ANALYSIS

27.1.3 GEOGRAPHIC PRESENCE

27.1.4 PRODUCT PORTFOLIO

27.1.5 RECENT DEVELOPMENTS

27.2 COOPERSURGICAL

27.2.1 COMPANY OVERVIEW

27.2.2 REVENUE ANALYSIS

27.2.3 GEOGRAPHIC PRESENCE

27.2.4 PRODUCT PORTFOLIO

27.2.5 RECENT DEVELOPMENTS

27.3 BOSTON SCIENTIFIC CORPORATION

27.3.1 COMPANY OVERVIEW

27.3.2 REVENUE ANALYSIS

27.3.3 GEOGRAPHIC PRESENCE

27.3.4 PRODUCT PORTFOLIO

27.3.5 RECENT DEVELOPMENTS

27.4 IDOMAN-MED 

27.4.1 COMPANY OVERVIEW

27.4.2 REVENUE ANALYSIS

27.4.3 GEOGRAPHIC PRESENCE

27.4.4 PRODUCT PORTFOLIO

27.4.5 RECENT DEVELOPMENTS

27.5 OLYMPUS

27.5.1 COMPANY OVERVIEW

27.5.2 REVENUE ANALYSIS

27.5.3 GEOGRAPHIC PRESENCE

27.5.4 PRODUCT PORTFOLIO

27.5.5 RECENT DEVELOPMENTS

27.6 OMNITECH SYSTEMS, INC

27.6.1 COMPANY OVERVIEW

27.6.2 REVENUE ANALYSIS

27.6.3 GEOGRAPHIC PRESENCE

27.6.4 PRODUCT PORTFOLIO

27.6.5 RECENT DEVELOPMENTS

27.7 MEDTRONIC

27.7.1 COMPANY OVERVIEW

27.7.2 REVENUE ANALYSIS

27.7.3 GEOGRAPHIC PRESENCE

27.7.4 PRODUCT PORTFOLIO

27.7.5 RECENT DEVELOPMENTS

27.8 VELDANA MEDICAL

27.8.1 COMPANY OVERVIEW

27.8.2 REVENUE ANALYSIS

27.8.3 GEOGRAPHIC PRESENCE

27.8.4 PRODUCT PORTFOLIO

27.8.5 RECENT DEVELOPMENTS

27.9 CHANNEL MEDSYSTEMS, INC.

27.9.1 COMPANY OVERVIEW

27.9.2 REVENUE ANALYSIS

27.9.3 GEOGRAPHIC PRESENCE

27.9.4 PRODUCT PORTFOLIO

27.9.5 RECENT DEVELOPMENTS

27.10 GYNESONICS

27.10.1 COMPANY OVERVIEW

27.10.2 REVENUE ANALYSIS

27.10.3 GEOGRAPHIC PRESENCE

27.10.4 PRODUCT PORTFOLIO

27.10.5 RECENT DEVELOPMENTS

27.11 RF MEDICAL CO., LTD.

27.11.1 COMPANY OVERVIEW

27.11.2 REVENUE ANALYSIS

27.11.3 GEOGRAPHIC PRESENCE

27.11.4 PRODUCT PORTFOLIO

27.11.5 RECENT DEVELOPMENTS

27.12 LINA MEDICAL APS

27.12.1 COMPANY OVERVIEW

27.12.2 REVENUE ANALYSIS

27.12.3 GEOGRAPHIC PRESENCE

27.12.4 PRODUCT PORTFOLIO

27.12.5 RECENT DEVELOPMENTS

27.13 JOHNSON & JOHNSON SERVICES, INC

27.13.1 COMPANY OVERVIEW

27.13.2 REVENUE ANALYSIS

27.13.3 GEOGRAPHIC PRESENCE

27.13.4 PRODUCT PORTFOLIO

27.13.5 RECENT DEVELOPMENTS

27.14 OCON THERAPEUTICS

27.14.1 COMPANY OVERVIEW

27.14.2 REVENUE ANALYSIS

27.14.3 GEOGRAPHIC PRESENCE

27.14.4 PRODUCT PORTFOLIO

27.14.5 RECENT DEVELOPMENTS

27.15 JUNE MEDICAL

27.15.1 COMPANY OVERVIEW

27.15.2 REVENUE ANALYSIS

27.15.3 GEOGRAPHIC PRESENCE

27.15.4 PRODUCT PORTFOLIO

27.15.5 RECENT DEVELOPMENTS

27.16 KARL STORZ ENDOSCOPY-AMERICA, INC.

27.16.1 COMPANY OVERVIEW

27.16.2 REVENUE ANALYSIS

27.16.3 GEOGRAPHIC PRESENCE

27.16.4 PRODUCT PORTFOLIO

27.16.5 RECENT DEVELOPMENTS

27.17 MGB BERLIN

27.17.1 COMPANY OVERVIEW

27.17.2 REVENUE ANALYSIS

27.17.3 GEOGRAPHIC PRESENCE

27.17.4 PRODUCT PORTFOLIO

27.17.5 RECENT DEVELOPMENTS

27.18 GYNEX

27.18.1 COMPANY OVERVIEW

27.18.2 REVENUE ANALYSIS

27.18.3 GEOGRAPHIC PRESENCE

27.18.4 PRODUCT PORTFOLIO

27.18.5 RECENT DEVELOPMENTS

28. RELATED REPORTS

29. CONCLUSION

30. QUESTIONNAIRE

31. ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Endometrial Ablation Devices Market is projected to grow at a CAGR of 6.1% during the forecast period by 2030.
The future market value of the Endometrial Ablation Devices Market is expected to reach USD 5.56 billion by 2030.
The major players in the Endometrial Ablation Devices Market are AEGEA Medical, Inc (U.S.), Boston Scientific Corporation (U.S.), CooperSurgical, Inc (U.S.), Hologic, Inc. (U.S.), IDOMAN-MED (Canada), Minerva Surgical, Inc (U.S.), Olympus Corporation (Japan), etc.
The countries covered in the Endometrial Ablation Devices Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, etc.

Industry Related Reports

Testimonial